Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/125180
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gauci, Luca | - |
dc.contributor.author | Scerri, Claudia | - |
dc.contributor.author | Mifsud, Maria | - |
dc.contributor.author | Gauci, Jonathan | - |
dc.date.accessioned | 2024-08-01T08:49:33Z | - |
dc.date.available | 2024-08-01T08:49:33Z | - |
dc.date.issued | 2024 | - |
dc.identifier.citation | Gauci, L., Scerri, C., Mifsud, M., & Gauci, J. (2024). Interstitial lung disease secondary to oxaliplatin-raltitrexed based chemotherapy. Malta Medical Journal, 36(3), 73-77. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/125180 | - |
dc.description.abstract | FOLFOX is a widely used regimen in the management of gastrointestinal malignancies and is a combination of 5-fluorouracil (5-FU), folinic acid, and oxaliplatin. Raltitrexed is an antifolate thymidylate synthase inhibitor which is used as an alternative when 5-FU is not tolerated. Here we present a case of interstitial lung disease as a rare side-effect of oxaliplatin and raltitrexed. Not much is known about the pathophysiology of the condition and most information available in the literature is taken from published case reports. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | University of Malta. Medical School | en_GB |
dc.rights | info:eu-repo/semantics/openAccess | en_GB |
dc.subject | Interstitial lung diseases | en_GB |
dc.subject | Oxaliplatin | en_GB |
dc.subject | Drugs -- Side effect | en_GB |
dc.subject | Chemotherapy | en_GB |
dc.title | Interstitial lung disease secondary to oxaliplatin-raltitrexed based chemotherapy | en_GB |
dc.type | article | en_GB |
dc.type | report | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.description.reviewed | peer-reviewed | en_GB |
dc.publication.title | Malta Medical Journal | en_GB |
Appears in Collections: | MMJ, Volume 36, Issue 3 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
MMJ36(3)CR3.pdf | 3.69 MB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.